UK Deep Brain Stimulation Devices Market Size & Outlook
UK deep brain stimulation devices market, 2018-2030 (US$M)
Related Markets
UK deep brain stimulation devices market highlights
- The UK deep brain stimulation devices market generated a revenue of USD 34.7 million in 2023 and is expected to reach USD 71.5 million by 2030.
- The UK market is expected to grow at a CAGR of 10.9% from 2024 to 2030.
- In terms of segment, dual channel was the largest revenue generating product in 2023.
- Single Channel is the most lucrative product segment registering the fastest growth during the forecast period.
Deep brain stimulation devices market data book summary
| Market revenue in 2023 | USD 34.7 million |
| Market revenue in 2030 | USD 71.5 million |
| Growth rate | 10.9% (CAGR from 2023 to 2030) |
| Largest segment | Dual channel |
| Fastest growing segment | Single Channel |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Single Channel, Dual Channel |
| Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Other key industry trends
- In terms of revenue, UK accounted for 3.0% of the global deep brain stimulation devices market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany deep brain stimulation devices market is projected to lead the regional market in terms of revenue in 2030.
- Sweden is the fastest growing regional market in Europe and is projected to reach USD 28.7 million by 2030.
Dual channel was the largest segment with a revenue share of 52.45% in 2023. Horizon Databook has segmented the UK deep brain stimulation devices market based on single channel, dual channel covering the revenue growth of each sub-segment from 2018 to 2030.
Various organizations, such as the Health Information and Quality Authority (HIQA), Medical Research Council, & Department of Health, conduct investigational studies and promote awareness about the potential advantages of deep brain stimulation therapy over therapeutics treatment, thereby contributing to the market growth.
For instance, the UK National Institute for Clinical Excellence (NICE) promotes incorporation of deep brain stimulation devices for patients resistant to the first line of treatment for PD or patients experiencing severe medication adverse effects.
Moreover, NHS Commissioning Board (Clinical Reference Group for Adult Neurosurgery) has issued a clinical commissioning policy for use of deep brain stimulation devices therapy in the treatment of movement disorders such as PD, tremors, and dystonia. These factors are expected to boost the demand for deep brain stimulation devices during the forecast period.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Deep Brain Stimulation Devices Market Scope
Deep Brain Stimulation Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UK deep brain stimulation devices market size, by product, 2018-2030 (US$M)
UK Deep Brain Stimulation Devices Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
